Blueberry as a source of bioactive compounds for the treatment of obesity, type 2 diabetes and chronic inflammation by Shi, Min et al.
1 
Blueberry as a source of bioactive compounds for the treatment of 1 
obesity, type 2 diabetes and chronic inflammation 2 
Min Shi, Hayley Loftus, Andrew J McAinch, Xiao Q Su* 3 
 4 
Centre for Chronic Disease, College of Health and Biomedicine, Victoria University,  5 
P.O. Box 14428, Melbourne, VIC 8001, Australia 6 
 7 
*Corresponding author 8 
Postal address:  9 
College of Health and Biomedicine  10 
Victoria University 11 
P.O. Box 14428  12 
Melbourne, Australia 8001 13 
Tel: +61-3-9919 2318 14 
Fax: +61-3-9919 2465 15 
Email: xiao.su@vu.edu.au 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
2 
Abstract 24 
Recent experimental and clinical studies suggest that consumption of blueberry products has 25 
potential health benefits in ameliorating the development of obesity and its related 26 
comorbidities, including type 2 diabetes (T2D) and chronic inflammation. Blueberry fruits are 27 
enriched with numerous bioactive components such as vitamins, phenolic acid and 28 
anthocyanins which could contribute to these protective effects. Possible mechanisms by which 29 
blueberries exert their beneficial properties include counteracting oxidative stress, regulating 30 
glucose metabolism, improving lipid profile, and lowering inflammatory cytokine levels in 31 
animal models and preliminary human trials. This review focuses on the potential role of 32 
blueberries as a functional food in the prevention and treatment of obesity and its comorbidities. 33 
Although the current evidence is promising, further randomized controlled studies in the longer 34 
term are needed to evaluate the role of blueberries and blueberry extracts to support human 35 
health. 36 
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1. Introduction 73 
Obesity is a medical condition in which excess body fat has accumulated to the extent that it 74 
may have a negative effect on health, causing reduced life expectancy and/or increased health 75 
problems (Haslam & James, 2005). Obesity causes a dysfunction in the metabolic system via 76 
a number of mechanisms, including initiation of endothelial dysfunction, increasing free radical 77 
production, lipid peroxidation and production of inflammatory cytokines (Chen, Chen, Wang 78 
& Liang, 2015; Neale, Batterham & Tapsell, 2016). Obesity predisposes to various diseases, 79 
especially obstructive sleep apnoea, cardiovascular disease (CVD), type 2 diabetes (T2D) and 80 
certain cancers (Haslam & James, 2005). Obesity is caused by excessive energy intake coupled 81 
with a lack of physical activity, however the complex interplay between genetics and 82 
environmental factors means that obesity is difficult to treat.   83 
Obesity increases the risk of developing T2D, a disease that is characterised by hyperglycaemia 84 
with an antecedent phase of insulin resistance (Musso, Gambino & Cassader, 2010; Zierath et 85 
al., 1996). Uncontrolled or poorly managed T2D can cause changes in the structure and 86 
function of major organs and tissues, including blood vessels, heart, nerves, eyes and kidneys 87 
which can lead to further serious and life threatening complications such as cardiac 88 
dysfunction, atherosclerosis, and nephropathy (Musso, Gambino & Cassader, 2010; Zierath et 89 
al., 1996).  In the early stages of T2D (or prediabetes), the pancreatic β-cells respond to 90 
hyperglycaemia by secreting increased amounts of insulin to facilitate the cellular uptake of 91 
the excess plasma glucose. Over time, insulin dependent cells become desensitised to insulin, 92 
resulting in β-cell dysfunction, insulin resistance and chronic hyperglycaemia if left untreated 93 
(Hajiaghaalipour, Khalilpourfarshbafi & Arya, 2015). Furthermore, dyslipidemia and an 94 
increase in pro-inflammatory cytokines have been shown to be associated with insulin 95 
resistance (Guo et al., 2012). Oxidative stress is another factor that can cause β-cell 96 
dysfunction, impaired glucose tolerance, insulin resistance and eventually T2D (Evans, 97 
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Goldfine, Maddux & Grodsky, 2003). Many studies have demonstrated that dietary 98 
antioxidants are effective in neutralizing or trapping reactive oxygen species (ROS) and thus 99 
antioxidants may be useful anti-diabetic agents (Defuria et al., 2009; Laplaud, Lelubre & 100 
Chapman, 1997; Martineau et al., 2006; Poudyal, Panchal & Brown, 2010). 101 
It is well known that obese and diabetic patients often present with dyslipidemia, characterized 102 
by elevated triglycerides (TG), low high density lipoprotein cholesterol (HDL-C) and 103 
predominance of small-dense low density lipoprotein (LDL) particles (Chan, Barrett & Watts, 104 
2014). Dyslipidaemia in visceral obesity is principally the result of insulin resistance, which 105 
perturbs the kinetics of both apolipoprotein B- (apoB) and apolipoprotein A- (apoA) containing 106 
lipoproteins (Chan et al., 2002; Martinez-Fernandez, Laiglesia, Huerta, Martinez & Moreno-107 
Aliaga, 2015). Effective management of dyslipidaemia in obesity and T2D therefore often 108 
requires lipid regulation.  109 
Obesity is related to chronic inflammation due to an increased infiltration of inflammatory cells 110 
into tissues such as liver and adipose tissue (Jung & Choi, 2014). Excess body fat, especially 111 
central adiposity, is correlated with a concomitant and persistent increase in low grade 112 
inflammation, which results in increased pro-inflammatory adipokines, cytokines and 113 
chemokines such as monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, nuclear 114 
factor-kappa B (NF-κB) and tumour necrosis factor alpha (TNF-α), and reduced production of 115 
anti-inflammatory adipokines, including adiponectin (Joseph, Edirisinghe & Burton-Freeman, 116 
2014; Matsuzawa, 2010).  117 
Dietary and/or complementary strategies to alleviate the metabolic complications of obesity 118 
and its related metabolic conditions have aroused considerable interest and are now under 119 
exploration as alternatives to pharmaceutical interventions. This paper will review the possible 120 
health benefits of one such dietary component, blueberries and blueberry extracts, emphasizing 121 
emerging evidence for its potential to ameliorate the impacts of obesity, T2D and chronic 122 
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inflammation. Moreover, data collected from studies on bioactive compounds of blueberries, 123 
in particular phytochemical constituents are included. The mechanisms of action of blueberries, 124 
as well as mechanistic and signalling pathways involved in the effects of blueberries on obesity 125 
and its related chronic diseases are also discussed. Figure 1 shows the proposed effects of 126 
blueberries on obesity and its related comorbidities, as well as associated metabolic and 127 
molecular pathways. 128 
2. Bioactive constituents in blueberries 129 
Blueberries are perennial flowering plants with indigo-coloured berries from the family 130 
Ericaceae within the genus Vaccinium (Luby, Ballington, Draper, Pliska & Austin, 1999). 131 
Many species of blueberry come predominantly from North America, however they are now 132 
produced in almost all countries, including Australia, New Zealand and European countries. 133 
Depending on the growing season and harvesting time, several types of blueberries are 134 
commonly available, including highbush blueberry plants (Vaccinium corymbosum L.), the 135 
rabbiteye blueberry (Vaccinium ashei Reade), lowbush blueberry plants or wild blueberry 136 
(Vaccinium angustifolium Aiton), and bilberry (Vaccinium myrtillus L.) (Maatta-Riihinen, 137 
Kamal-Eldin, Mattila, Gonzalez-Paramas & Torronen, 2004; Michalska & Lysiak, 2015). 138 
Bilberry is a European wild blueberry that contains a higher content of anthocyanins (ACNs) 139 
than cultivated blueberry species (Chu, Cheung, Lau & Benzie, 2011).  Blueberries are 140 
nutritious fruits as they are rich sources of carbohydrates, vitamins and minerals (Liu,  et al., 141 
2015b). Blueberries are also a good source of dietary fibres that constitutes 3%–3.5% of fruit 142 
weight (Michalska & Lysiak, 2015). In addition, blueberries have a high content of several 143 
phytochemicals, including ascorbic acid and phenolics. Many of the proposed beneficial health 144 
effects associated with blueberry consumption are linked to the bioactive properties of the 145 
phytochemical constituents. The predominant bioactive components contained in blueberries 146 
are ascorbic acid, flavonols (including kaempferol, quercetin and myricetin), hydroxycinnamic 147 
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acids (including caffeic acids, ferulic acids and coumaric acids), hydroxybenzoic acids 148 
(including gallic acids and procatchuic acids), pterostilbene, resveratrol, and ACNs. The 149 
potential benefits of blueberry for human health have received much attention in recent years 150 
due to these bioactive components (Chen, Li & Xu, 2010; Koupy, Kotolova & Kucerova, 151 
2015).  152 
2.1 Ascorbic acid  153 
Blueberries are rich in ascorbic acid, which is a water-soluble compound that fulfils several 154 
roles in living systems, including enhancing immunity and reducing inflammation (Liu, et al., 155 
2015a; Nile & Park, 2014). Ascorbic acid is an antioxidant vitamin and is widely distributed in 156 
various blueberry species and varieties. On average 100 g of blueberries provide 10 mg of 157 
ascorbic acid, which is equal to one third of the daily recommended dietary intake (Capra, 158 
2006; Prior et al., 1998), however varying amounts of ascorbic acid have been reported in 159 
different species. The content of ascorbic acid in highbush blueberries (total eight species) 160 
ranged from 5 to 15 mg/100 g of fresh fruit, compared with 16.4 mg/100 g in lowbush blueberry 161 
(Prior et al., 1998). Fresh bilberry only contains small quantities of ascorbic acid (3 mg/100 g) 162 
(Graff & Upton, 2001). Rabbiteye blueberries contain different amounts of ascorbic acid due 163 
to the variety of species. Six species of rabbiteye blueberry were found to have a lower amount 164 
of ascorbic acid (6 to 10 mg/100g) compared to the average content  (Prior et al., 1998). 165 
However, it has been reported that the concentration of ascorbic acid was high and up to 41 166 
mg/100 g in fresh Ochlockonee fruit, belonging to the rabbiteye species, and 25 mg/100 g in 167 
fresh highbush blueberry (Gündüz, Serçe & Hancock, 2015).  There are also other contributors 168 
to the potential variation in ascorbic acid in blueberries, such as cultivation, climate, weather 169 
conditions and storage time. The concentration of ascorbic acid decreases when conditions 170 
such as oxygen level and temperature are suboptimal during storage. Moreover, after storage 171 
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for 8-days at 20 °C the content of ascorbic acid in fresh fruit decreases by  27% (Kalt, Forney, 172 
Martin & Prior, 1999).   173 
2.2 Phenolics 174 
Phenolic compounds belong to a wide and heterogeneous group of chemical substances that 175 
possess one or more aromatic rings with a conjugated aromatic system and one or more 176 
hydroxyl groups.  Phenolic compounds occur in free or conjugated forms with sugars, acids, 177 
and other biomolecules as water-soluble (phenolic acids, flavonoids and quinones) or water-178 
insoluble compounds (condensed tannins) (Skrovankova, Sumczynski, Mlcek, Jurikova & 179 
Sochor, 2015). The total content of phenolic compounds in blueberries is highly variable, with 180 
variation upwards of 10-times higher or lower (e.g. ranges from 48 up to 304 mg/100 g of fresh 181 
fruit weight (up to 0.3%) (Ehlenfeldt & Prior, 2001; Moyer, Hummer, Finn, Frei & Wrolstad, 182 
2002) depending on the cultivar (Taruscio, Barney & Exon, 2004), growing conditions and 183 
maturity (Castrejón, Eichholz, Rohn, Kroh & Huyskens-Keil, 2008), and its estimation may 184 
vary depending on the method of analysis (De Souza et al., 2014; Maatta-Riihinen, Kamal-185 
Eldin, Mattila, Gonzalez-Paramas & Torronen, 2004). Phenolic compounds presented in 186 
blueberries contain stilbenoids, tannins [hydrolyzable tannins (gallotannins and ellagitannins) 187 
and condensed tannins (proanthocyanidins)], and flavonoids, including flavan-3-ols, ACNs, 188 
and their polymeric condensation products, flavanones, flavonols (i.e., kaempferol, quercetin, 189 
myricetin) and flavones (Borges, Degeneve, Mullen & Crozier, 2010; Seeram, 2008; Taruscio, 190 
Barney & Exon, 2004). High amounts of phenolics are found in blueberry and account for 50–191 
80% of the total polyphenol content, which can reach a concentration of up to 3000 mg/kg 192 
fresh weight (Kuntz et al., 2015; Muller, Schantz & Richling, 2012).  193 
Tannins are a unique group of phenolic metabolites with molecular weights between 500 and 194 
30,000 Da, which are widely distributed in all berry species and specific berries may contain 195 
an abundance of a particular group of tannins (Ferreira, Gross, Kolodziej & Yoshida, 2005; 196 
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Serrano, Puupponen-Pimia, Dauer, Aura & Saura-Calixto, 2009). It has been suggested that 197 
tannins may have therapeutic potential in the treatment of diabetes, mainly  through two ways; 198 
(i) they may lower glucose levels by delaying intestinal glucose absorption and an insulin-like 199 
effect on insulin-sensitive tissues, and (ii) they may delay the onset of insulin-dependent T2D 200 
by regulating the antioxidant environment of pancreatic β-cells (Serrano, Puupponen-Pimia, 201 
Dauer, Aura & Saura-Calixto, 2009).   Previous studies showed that tannins were an effective 202 
inhibitor of intestinal α-glucosidase activity (Mcdougall et al., 2005; Toda, Kawabata & Kasai, 203 
2001), and they also inhibited glucose uptake in intestinal cells (Song et al., 2002). 204 
Proanthocyanidins, known as condensed tannins, are the most widely represented products of 205 
plant secondary metabolism throughout nature, after lignins (Gu et al., 2003). Blueberries 206 
contain predominantly proanthocyanidins, compared with other berries, such as blackberries, 207 
black raspberries, red raspberries, and strawberries, which contain predominantly ellagitannins 208 
(Seeram, 2008). Therefore, the unique biological properties of blueberries may be associated 209 
with the specific chemical structures of tannins.  The distinct biological effects of blueberries 210 
on neuronal function in different regions of the brain and behaviour in aging animals may be 211 
due to the effects of individual classes of tannins (Shukitt-Hale, Carey, Jenkins, Rabin & 212 
Joseph, 2007).  213 
Flavonoids are a large heterogenic group of benzo-γ-pyron derivatives, which are abundantly 214 
present in food products and beverages derived from fruits and vegetables (Heo & Lee, 2004). 215 
Many physiological benefits of flavonoids have been attributed to their antioxidant and free 216 
radical scavenging properties to exert positive health effects on chronic disease, including 217 
cancer and neurodegenerative disorders (Lau, Bielinski & Joseph, 2007; Neto, 2007; Nile & 218 
Park, 2014). Blueberries have also been demonstrated to contain high levels of flavanoid 219 
compounds, ranking them among the foods showing the highest antioxidant activity (Barberis 220 
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et al., 2015; Borges, Degeneve, Mullen & Crozier, 2010; Moyer, Hummer, Finn, Frei & 221 
Wrolstad, 2002).  222 
The predominant flavonoids in blueberries are quercetin glycosides (quercetin-3-galactoside, 223 
quercetin-3-glucoside, quercetin-3-rutinoside) and myricetin glycosides (myricetin-3-224 
glucoside, myricetin-3-rhamnoside) (Skrovankova, Sumczynski, Mlcek, Jurikova & Sochor, 225 
2015). Quercetin, one of the most frequently researched flavonoids, has shown antioxidative 226 
and anti-carcinogenic activities to protect against oxidative stress (Heo & Lee, 2004). The 227 
content of quercetin in blueberry and bilberry were 24 and 30 mg/kg fresh fruit, respectively, 228 
which were accounted to 50% and 60% of total flavonoids (Hakkinen, Karenlampi, Heinonen, 229 
Mykkanen & Torronen, 1999). Several in vitro studies indicated its efficacy in the prevention 230 
of different types of cancer induced by potent carcinogens, such as benzo(a)pyrene, 231 
azoxymethane, and N-nitrosodiethylamine (Kamaraj et al., 2007; Seufi, Ibrahim, Elmaghraby 232 
& Hafez, 2009; Volate, Davenport, Muga & Wargovich, 2005) and its anti-cancer capability 233 
has also been demonstrated in animal models (Caltagirone et al., 2000; Devipriya, Ganapathy 234 
& Shyamaladevi, 2006). Myricetin is a bioflavonoid abundant in berries and it was reported 235 
that the anti-diabetic effectiveness of myricetin is due to its anti-inflammatory activity   (Fu et 236 
al., 2013; Wang et al., 2010; Wu, Zheng, Gong & Li, 2016). The content of total flavonoids  in 237 
blueberries ranged from 2.5 to 387.48 mg/100 g fresh fruit (Hakkinen, Karenlampi, Heinonen, 238 
Mykkanen & Torronen, 1999; Sellappan, Akoh & Krewer, 2002), depending on the species 239 
and the method used (Borges, Degeneve, Mullen & Crozier, 2010; Buran et al., 2014; Taruscio, 240 
Barney & Exon, 2004). Taruscio et al (2004) reported the contents of flavonols extracted from 241 
eight blueberry species, including three species of highbush blueberry, three species of half-242 
highbush blueberry and two species of bilberry. The HPLC analytical results showed that 243 
myricetin and quercetin were the principal flavonols in blueberries (Taruscio, Barney & Exon, 244 
2004). Bilberry contained the highest level of quercetin (163.6 µg/g in frozen fruit) followed 245 
11 
by half-highbush blueberry (102.5 µg/g in frozen fruit) and highbush blueberry (86.4 µg/g in 246 
frozen fruit) (Taruscio, Barney & Exon, 2004). Bilberry also contained the highest content of 247 
myricetin (200 µg/g in frozen fruit) at the level of nearly 10 and 15-fold higher , compared to 248 
half-highbush blueberry (19.8 µg/g in frozen fruit) and highbush blueberry (12.9 µg/g in frozen 249 
fruit) (Taruscio, Barney & Exon, 2004).  250 
Anthocyanins (ACNs), pigments that contribute to the intense colours in blueberry, have been 251 
shown to exhibit numerous bioactive properties, such as anti-inflammatory, antioxidant and 252 
anti-cancer activities (Faria et al., 2010; Vendrame, Daugherty, Kristo, Riso & Klimis-Zacas, 253 
2013; Zepeda et al., 2012). The most common anthocyanidin aglycones are peonidins, 254 
pelargonidins, malvidins, delphinidins, cyanidins and petunidins (Li, Wang, Guo & Wang, 255 
2011). These then combine with organic acids and sugars to generate various ACNs (Figure 2) 256 
(Rodriguez-Mateos, Heiss, Borges & Crozier, 2014). Muller et al (2012) found that malvidin 257 
and delphinidin are the main components and constitute almost 72% of all identified 258 
anthocyanins (Muller, Schantz & Richling, 2012). However, other studies reported less 259 
concentrations of malvidin (22%–33%) and delphinidin (27%–40%) in five genotypes of 260 
blueberries  (Cho, Howard, Prior & Clark, 2004). There are up to 27 different ACNs found in 261 
blueberries (Prior et al., 1998). The content and type of ACNs depend on the species, fruit size, 262 
ripening stage, as well as on climatic, pre-harvest environmental conditions and storage 263 
(Muller, Schantz & Richling, 2012; Scibisz & Mitek, 2007). The concentration of ACNs is up 264 
to 800 mg/100 g fresh weight in highbush species and more than 1000 mg/100 g fresh fruit in 265 
lowbush species (Cho, Howard, Prior & Clark, 2004; Hosseinian & Beta, 2007). The high 266 
content of ACNs in different Vaccinium species is a main contributor to their antioxidant 267 
activity and is responsible for about 84% of total antioxidant capacity (Borges, Degeneve, 268 
Mullen & Crozier, 2010). Whereas ascorbic acid was only found to contribute to 10% of the 269 
antioxidant capacity despite being present in a significant amount (Barberis et al., 2015). 270 
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Although structural and categorical diversity can be noticed among bioactive constituents in 271 
blueberries, other factors influence this diversity including, but are not limited to, species and 272 
genetic makeup of blueberries, agricultural practices, growing condition, season of harvest, 273 
irrigation, and storage of the fruits (Castrejón, Eichholz, Rohn, Kroh & Huyskens-Keil, 2008; 274 
Scibisz & Mitek, 2007). 275 
2.3 Phenolic acid 276 
Phenolic acid, in general, describes phenols that possess one carboxylic acid functionality 277 
(Robbins, 2003). Phenolic acids account for approximately one-third of the dietary phenols 278 
present in plants (Zadernowski, Naczk & Nesterowicz, 2005). Researchers have become 279 
increasingly interested in phenolic acids and their derivatives due to their high nutritional and 280 
antioxidant properties in foods (Chalas et al., 2001; Zadernowski, Naczk & Nesterowicz, 281 
2005). Clifford (1999) estimated that the average amount of phenolic acids consumed is 282 
between 25 mg and 1 g daily (Clifford, 1999). In blueberries, only a minor fraction of phenolic 283 
acid exists as free forms, with the majority of phenolic acid existing in conjugated forms, which 284 
are linked with esters, amides and glycosides (Robbins, 2003). Vanillic acid, hydroxycinnamic 285 
acids, ferulic acid, caffeic acid, chlorogenic acid, p-coumaric acid, gallic acid and salicylic acid 286 
are the principal phenolic acids in blueberry (Zadernowski, Naczk & Nesterowicz, 2005). 287 
Among them, chlorogenic acid is the most abundant in blueberry species (Kang, Thakali, 288 
Jensen & Wu, 2015), however its content was highly variable between species with highbush 289 
and lowbush blueberry varieties ranging from 34.3 to 113.8 mg/100 g fresh weight (Rodriguez-290 
Mateos, Cifuentes-Gomez, Tabatabaee, Lecras & Spencer, 2012). This high concentration of 291 
chlorogenic acid present in blueberries is likely to  contribute to the anti-inflammatory effects 292 
of blueberries (Santos, Almeida, Lopes & De Souza, 2006). A previous study showed that 293 
seven phenolic acid mixture including hydroxycinnamic acid, hippuric acid, 3-(3-294 
hydroxyphenyl)propionic acid,  3-(4-hydroxyphenyl) propionic acid, hydroxyphenylacetic 295 
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acid, hydroxybenzoic acid and ferulic acid from blueberry inhibited lipopolysaccharide (LPS)-296 
induced production of pro-inflammatory cytokine, IL-6 and TNF-α by the reduction of 297 
mitogen-activated protein kinase, Jun amino-terminal kinases (JNK), p38 and Erk1/2 298 
phosphorylation  in murine macrophage cell line RAW 264.7 (Xie et al., 2011).  299 
3. Effects on body weight and fat mass  300 
The anti-obesity effects of blueberries and blueberry extracts have been investigated in both 301 
clinical studies and also several animal models, such as Obese Zucker rats, KKAy mice, 302 
C57BL/6J mouse and Sprague-Dawley rats (Prior et al., 2010; Seymour et al., 2009; Seymour 303 
et al., 2011; Vuong et al., 2009). Tables 1 and 2 summarise the impacts of consumption of 304 
blueberries and blueberry extracts on obesity in animal models and human trials.   305 
3.1 Whole fruit or juice 306 
It has been reported that body weight, liver weight, and total fat weight were significantly 307 
reduced in Obese Zucker rats fed a low-fat diet (LFD) combined with 2% (w/w) whole 308 
highbush blueberry powder (Seymour et al., 2009; Seymour et al., 2011). These results are 309 
consistent with the study of Prior et al. (2010) who reported that supplementation with 310 
blueberry juice (0.2 mg/mL) prevented weight gain in C57BL/6J mice that were fed a HFD 311 
(45% of kcal from fat). Furthermore, Voung et al. (2009) showed that incorporating blueberry 312 
juice in drinking water significantly reduced weight gain in obese KKAy mice. These positive 313 
results possibly related to the improved glucose tolerance and enhanced insulin sensitivity seen 314 
in these animals (Vuong et al., 2009). Contrary to these results, blueberry supplementation did 315 
not affect the  body weight of C57BL/6J mice fed a HFD (60% of energy) with 4% (w/w) 316 
whole blueberry powder for 8 weeks (Defuria et al., 2009) or of Sprague-Dawley rats 317 
supplemented with 10% freeze-dried whole blueberry for 3 weeks (Seymour et al., 2009). 318 
Another study found no significant differences in weight gain after the 12 weeks of feeding 319 
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C57BL/6J mice with 5% bilberry compared with mice fed a HFD (45% kcal fat) (Mykkanen 320 
et al., 2012). Conversely, Prior et al. (2008) demonstrated that diets supplemented with 10% 321 
whole blueberry powder increased adiposity and body weight in C57BL/6J mice fed a HFD. 322 
However, blueberry-fed mice in this study consumed approximately 12% more energy/day 323 
than the control HFD group, which may have contributed to these outcomes (Prior et al., 2008). 324 
Most of the clinical studies have shown that dietary supplementation with whole blueberry or 325 
blueberry juice failed to reduce body weight and waist circumference (Basu et al., 2010; Qin 326 
et al., 2009; Stull, Cash, Johnson, Champagne & Cefalu, 2010). This has been demonstrated in 327 
a randomised controlled trial with 48 obese participants (4 males and 44 females) in which 328 
participants consumed a freeze-dried blueberry beverage (50 g freeze-dried blueberries 329 
equivalent to 350 g of fresh blueberries) or water for 8 weeks.  There were no significant 330 
differences observed in waist circumference, body weight or dietary intakes between the 331 
treatment group and the control group (Basu et al., 2010). Similar results were also observed 332 
in non-diabetic obese participants who were supplemented with either 22.5 g blueberry powder 333 
or a placebo twice daily for 6 weeks in that there were no significant differences observed 334 
between the treatment and control groups in body weight, adiposity and energy or 335 
macronutrient consumption (Stull, Cash, Johnson, Champagne & Cefalu, 2010). Overall there 336 
is limited evidence to suggest that blueberry supplementation alone affects adiposity in obese 337 
or overweight individuals. Future studies are encouraged to focus on calorie restriction and 338 
longer intervention periods in conjunction with supplementation, however whether this will 339 
result in clinically significant improvements in weight loss compared to calorie restriction 340 
alone is uncertain.  341 
3.2 Extracts of blueberries 342 
Several studies have examined the effects of blueberry extracts, particularly ACNs from fresh 343 
blueberry fruit, juice and peel on control of body weight and have indicated that the anti-obesity 344 
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capability of blueberry extract is quite different to whole fruit or juice (Prior et al., 2010; Prior 345 
et al., 2009; Prior et al., 2008). Although the reasons for these disparities are not clear, one 346 
possible explanation is that there are different types and amounts of bioactive constituents 347 
contained in blueberry and its products, which might change the response to extracts from 348 
blueberry, compared with purification or single components. For instance, blueberry juice 349 
contains not only ACNs but also other components such as procyanidins, chlorogenic acid, and 350 
other water-soluble compounds including sugars (Prior et al., 2010). Another possibility is that 351 
there are some specific components, such as uronic acids, neutral sugars, noncellulosic sugars 352 
including xylose and arabinose, or other factors as an obstruction in whole blueberry to 353 
counteract the potential benefit of blueberry consumption (Vicente et al., 2007). Wu et al. 354 
(2013) showed that ACNs from blueberry juice decreased body weight up to 7.3% in dietary-355 
induced models of obesity. Dietary-induced weight gain, perirenal adipose tissue and 356 
epididymal weights were significantly lowered in male Sprague-Dawley rats fed a HFD 357 
supplemented with blueberry peel extracts for 5 weeks compared to an equivalent control 358 
group. It has been reported that blueberry peel extracts may potentially affect obesity by a 359 
reduction of adipogenesis and inhibition of fat accumulation through the PI3K/Akt/GSK3β 360 
pathway in 3T3-L1 preadipocytes (Song et al., 2013).  361 
Further studies are required to assess the effect of ACNs consumption at various doses to 362 
establish the specific concentration of ACNs required for ameliorating the development of 363 
obesity. According to a previous study conducted by Prior et al. (2010), the low concentration 364 
of ACNs (0.2 mg/mL) decreased retroperitoneal and epididymal fat (% body weight) by 31% 365 
and 25%, respectively in mice fed a LFD, and 26% and 29%, respectively in mice fed a HFD 366 
for 72 days. However, retroperitoneal and epididymal fat levels were not decreased in HFD-367 
fed mice treated with higher concentration of ACNs (1.0 mg/mL) but were similar to, or slightly 368 
higher than the HFD mice without ACNs (Prior et al., 2010). ACNs intake was measured as 369 
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0.6 and 3.4 mg/day for each mouse fed a LFD, and 0.5 and 1.8 mg/day for each mouse fed a 370 
HFD, according to liquid intake with the low concentration (0.2 mg/mL) and high 371 
concentration (1.0 mg/mL) of ACNs (Prior et al., 2010). This indicated that low concentrations 372 
of ACNs are potentially more beneficial compared to higher doses; however the exact reasons 373 
for this observation are unknown. Conversely, another independent study has demonstrated 374 
that supplementation of a higher concentration (2.8 mg/day/mouse) of purified ACNs for 92 375 
days significantly prevented the development of obesity, but 3.75 mg/day/mouse  failed to 376 
prevent body weight gain in HFD induced obese mouse model (Prior et al., 2008). Thus it 377 
appears to be no clear dose dependent effect and further investigation is needed to define the 378 
effective dose of ACNs or blueberries for body weight control in cases of obesity.  379 
4. Effect on glucose metabolism and insulin signalling 380 
Animal models (Table 1) and clinical studies (Table 2) have demonstrated that supplementation 381 
or consumption of blueberry or blueberry bioactive compounds cause changes in glucose 382 
metabolism and improve insulin sensitivity. 383 
 4.1 Whole fruit or juice 384 
Supplementation of 2% freeze-dried blueberry powder for 13 weeks in Obese Zucker rats have 385 
demonstrated significant reductions in glucose, fasting insulin and insulin resistance, as 386 
indicated by the Homeostasis Model Index of Insulin Resistance (HOMA-IR) (Seymour et al., 387 
2009; Seymour et al., 2011). Likewise, Vuong et al. (2009) showed that fermented blueberry 388 
juice by the Serratia vaccinii bacterium significantly reduced blood glucose levels and 389 
maintained the glycaemia of pre-diabetic KKAy mice to a normal level. These results indicate 390 
that blueberry intake could reduce phenotypes of diabetes in obesity-prone rats by regulating 391 
glucose metabolism. Conversely, Prior et al. (2008) reported that long term supplementation 392 
with freeze-dried whole blueberry powder did not affect the results of a glucose tolerance test 393 
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that were administered to C57BL/6J obese mice. These inconsistent results mainly depend on 394 
the variation of animal models, the duration of the treatment, and the dose of bioactivity 395 
components in blueberry. Furthermore, clinical studies have also reported that blueberry 396 
supplementation did not show the impact on fasting serum glucose (Basu et al., 2010; 397 
Kolehmainen et al., 2012; Stull, Cash, Johnson, Champagne & Cefalu, 2010). Specifically, 398 
Basu et al. (2010) documented that a freeze-dried blueberry beverage (50 g freeze-dried 399 
blueberries equivalent to 350 g of fresh blueberries) for 8 weeks to 48 obese participants (4 400 
males and 44 females) was not able to significantly change their serum glucose concentration. 401 
Also, glucose and insulin responses did not differ between the bilberry group (400 g fresh fruit) 402 
and the control group, when obese individuals consumed a diet rich in bilberries for 8 weeks 403 
(Kolehmainen et al., 2012). Likewise, no changes was observed in serum glucose during the 404 
intervention with 22.5 g blueberry bioactive twice daily for 6 weeks, although insulin 405 
sensitivity was improved significantly more in the blueberry group compared to the placebo 406 
group in participants who were obese, nondiabetic, and insulin resistant (Stull, Cash, Johnson, 407 
Champagne & Cefalu, 2010). In vitro studies have however consistently shown that blueberry 408 
improves glucose uptake. For instance, 6-h incubation of fermented blueberry juice with and 409 
without insulin enhanced glucose uptake into the adipocyte and muscle cells and increased the 410 
phosphorylation/activation of proteins in the insulin-independent pathway (i.e., AMP-activated 411 
protein kinase) but had no effect on phosphorylation of key  proteins in the insulin-dependent 412 
pathway (i.e., AKT and ERK1/2) (Vuong, Martineau, Ramassamy, Matar & Haddad, 2007). 413 
These findings showed that the bioactive components in fermented blueberry improved glucose 414 
uptake into the cells via an insulin-independent mechanism. These positive cellular mechanistic 415 
studies provide evidence on the improvement of insulin sensitivity in vitro, however why the 416 
variation in the in vivo studies remains to be determined. 417 
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4.2 Extracts from blueberries 418 
While the effects of blueberry juice on glucose tolerance in vivo is varied, supplementation 419 
with ACNs appear to have a more positive effect as it has been previously indicated that fasting 420 
serum glucose concentrations were decreased and oral glucose tolerance was increased in mice 421 
fed a HFD supplementation with ACNs compared to blueberry juice (Prior et al., 2010). This 422 
result is possibly attributed to other constituents in blueberry juice such as procyanidins, 423 
chlorogenic acid, and other water-soluble compounds including sugars, which are not present 424 
in ACNs. It is possible that this beneficial effect of ACNs on glucose tolerance may be due to 425 
a direct effect on the liver as blueberry ACNs (0.05–10 mg/mL) have been demonstrated to 426 
significantly reduce glucose production by 24–74% in H4IIE hepatocytes (Roopchand et al. 427 
2013). In addition, diabetic C57BL/6J mice supplemented with 500 mg/kg body weight of a 428 
phenolic-rich fraction or an anthocyanin-rich fraction showed reductions in blood glucose 429 
levels by 33% and 51%, respectively. In these fractions, 287 mg/g ACNs was in a phenolic-430 
rich fraction, while 595 mg/g ACNs (cyanidin-3-glucoside equivalents) was in an anthocyanin-431 
rich fraction, which suggested that higher ACNs concentration in different fractions may 432 
contribute to more hypoglycaemic activity of the extracts (Grace et al., 2009).  433 
Bilberry extract also reduces blood glucose level and enhances insulin sensitivity in diabetic 434 
KKAy mice (Sasaki et al., 2007). Furthermore, in the same study, the glucose transporter 4 435 
(Glut4) was upregulated and retinol binding protein 4 (RBP4) was downregulated in the white 436 
adipose tissue in bilberry extract group (Sasaki et al., 2007). These results indicated that 437 
bilberry extract has a potent effect on glucose metabolism through the regulation of Glut4-438 
RBP4 system. The beneficial effects of bilberry extracts are also supported in a human trial 439 
demonstrating that insulin and postprandial glycaemia was significantly reduced in diabetic 440 
volunteers supplemented a bilberry extract (containing 36 % (w/w) of ACNs which is 441 
equivalent to about 50 g of fresh bilberry) for 2 weeks, compared with the placebo group (a 442 
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polysaccharide drink and equivalent to 75 g of glucose) (Hoggard et al., 2013). A longer 443 
intervention (4 weeks) with the extracts (providing 50 mg 3,4-caffeoylquinic (chlorogenic) 444 
acid, and 50 mg myricetin) from blueberry leaf  has also shown that fasting plasma glucose 445 
was reduced significantly in diabetic volunteers (Abidov, Ramazanov, Jimenez Del Rio & 446 
Chkhikvishvili, 2006). However, other clinical studies have indicated that there were no 447 
significant differences in fasting blood glucose between the treatment and the control groups 448 
after dietary supplementation with ACNs for 12 (Qin et al., 2009) or 24 weeks (Zhu et al., 449 
2013). 450 
There are up to 27 different ACNs present in blueberry, however, only several specific ACNs 451 
exhibit strong hypoglycaemic capacity (Roopchand, Kuhn, Rojo, Lila & Raskin, 2013).  Grace 452 
et al. (2009) observed that in diabetic C57BL/6J mice treated with 300 mg/kg of the pure ACN 453 
delphinidin-3-O-glucoside (D3G) or malvidin-3-O-glucoside (M3G), M3G decreased blood 454 
glucose to a greater extent compared to D3G. It is likely that the metabolism and bioavailability 455 
affects the magnitude of bioactivity in different types of ACNs. Cyanidin-3-glucoside (C3G) 456 
is the predominant ACN in blueberries (Wang, Zhao, Wang, Huo & Ji, 2016). Several studies 457 
have shown that isolated C3G improved insulin sensitivity and hyperglycaemia in animal 458 
models of diabetes (Guo et al., 2012; Liu, Li, Zhang, Sun & Xia, 2014; Sasaki et al., 2007).  459 
There are several pathways involved in these effects, such as the modulation of Glut4-RBP4 460 
system (Sasaki et al., 2007), the c-Jun N terminal kinase/forkhead box O1 signalling pathway  461 
(Guo, Guo, Jiang, Li & Ling, 2012) and adiponectin activating cAMP-PKA-eNOS signalling 462 
pathways (Liu, Li, Zhang, Sun & Xia, 2014).  463 
In animal studies, following supplementation with blueberry extracts or pure ACNs (C3G), 464 
ACNs were detected in the liver, blood, kidney and ocular tissues with an intact form 465 
suggesting that ACNs and/or their metabolites can be distributed to various tissues via blood 466 
and are therefore expected to regulate metabolic changes in the body (Ichiyanagi, Shida, 467 
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Rahman, Hatano & Konishi, 2006; Mcghie, Ainge, Barnett, Cooney & Jensen, 2003; 468 
Takikawa, Inoue, Horio & Tsuda, 2010; Tsuda, Horio & Osawa, 1999). An in vitro study has 469 
also reported that glucose uptake was increased in C2C12 cells treated with extracts from the 470 
root, leaf and stem of lowbush blueberry, and in 3T3-L1 cells only treated with extracts from 471 
root and stem of lowbush blueberry (Martineau et al., 2006). These results were consistent with 472 
an in vivo study that also demonstrated ACNs components in different fractions specifically 473 
contributed to improving hypoglycaemic activity in diabetic C57BL/6J mice (Grace et al., 474 
2009). However, the fruit extract in lowbush blueberry did not show any effect on glucose-475 
stimulated insulin secretion or glucose uptake in β TC-tet pancreatic β cells (Martineau et al., 476 
2006).  Since the ACNs composition extracted from the fruit are completely different, 477 
compared to those extracted from the leaf, root and stem, the hypoglycaemic compounds from 478 
the blueberry in vitro studies perhaps do not have the same effect in vivo due to the different 479 
mechanisms of action. 480 
5. Effect on lipid metabolism 481 
5.1 Whole fruit and fruit juice 482 
Diets enriched with blueberries have been reported to improve dyslipidaemia (Seymour et al., 483 
2009; Seymour et al., 2011; Vendrame, Daugherty, Kristo & Klimis-Zacas, 2014b; Wu et al., 484 
2013). Plasma TG and total cholesterol (TC) concentrations were significantly reduced in 485 
Obese Zucker rats supplemented with 8% wild blueberry for 8 weeks (Vendrame, Daugherty, 486 
Kristo & Klimis-Zacas, 2014a) or 2% blueberry powder for 13 weeks in both LFD and HFD 487 
groups compared with the control groups (Seymour et al., 2009). These observations were also 488 
supported by a reduction in serum TC and low density lipoprotein cholesterol (LDL-C), as well 489 
as the levels of liver TG and TC following consumption of blueberry juice.  although  the 490 
contents of liver lipids and cholesterol were not changed in C57BL/6 mice (Wu et al., 2013). 491 
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The consumption of 1%, 2% and 4% blueberry-supplements  for 8 weeks has significantly 492 
reduced the TC and LDL-C concentrations in pigs (Kalt et al., 2008).  493 
The possible pathways involved in the anti-dyslipidaemic effect of blueberries include the 494 
regulation and expression of key enzymes such as lipoprotein lipase (LPL) (Wei et al., 2011), 495 
fatty acid synthase (Tsuda, Ueno, Kojo, Yoshikawa & Osawa, 2005) and ATP-binding cassette 496 
transporter 1 (ABCA1) (Xia et al., 2005) which are involved in TG and cholesterol metabolism. 497 
Furthermore, the expression of transcription factors such as sterol regulatory element-498 
binding transcription factor (SREBP) and peroxisome proliferator-activated receptor (PPAR) 499 
in bioactive tissues could also explain the observed effects of blueberry consumption on lipid 500 
profiles (Cutler, Petersen & Anandh Babu, 2016; Vendrame, Daugherty, Kristo & Klimis-501 
Zacas, 2014a). In a recent study, the expression of PPARα and PPARγ in Obese Zucker rats 502 
were increased in the abdominal adipose tissue (AAT), while that of total SREBP-1 was 503 
decreased in both the liver and the AAT of the rats following consumption of a diet enriched 504 
with 8% wild blueberry for 8 weeks (Vendrame, Daugherty, Kristo & Klimis-Zacas, 2014a). 505 
The activation of PPARα and PPARγ following blueberry consumption could partly explain 506 
such an effect on lipid accumulation in blood and bioactive tissues. The activation of PPARα 507 
is related to enhanced fatty acid uptake, conversion into acyl-CoA derivatives, and further 508 
catabolism (Pawlak, Lefebvre & Staels, 2015); moreover, the activation of PPARγ in adipose 509 
tissue is known to induce differentiation of preadipocytes and TG storage (Ferre, 2004). The 510 
down-regulation of the expression of SREBP-1 also helps to explain the reduction in TG and 511 
TC in the Obese Zucker rats supplemented with blueberry diet, since SREBP-1 isoforms 512 
promote the synthesis and accumulation of TG and cholesterol via the induction of multiple 513 
enzymes (Horton, Goldstein & Brown, 2002). Similar results were also observed by Seymour 514 
et al (2011) which showed blueberry intake increased PPARα and PPARγ activity in skeletal 515 
muscle in both HFD and LFD fed rats. In addition, the intake of blueberry significantly affected 516 
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mRNA of several genes related to fat storage and glucose uptake, such as PPARγ co-activator 517 
1α, Acyl-CoA oxidase, fatty acid synthase, fatty acid-CoA ligase, Glut4 and insulin receptor 518 
substrate 1 in both skeletal muscle and retroperitoneal abdominal fat in HFD induced rats 519 
(Seymour et al., 2011). With regards to improving lipid profile, clinical studies of blueberry 520 
supplementation have not supported those of animal studies with freeze-dried wild blueberries 521 
showing no effect on TG, TC, HDL-C and LDL-C levels in obese subjects (Basu et al., 2010), 522 
in subjects with developing CVD risk (Riso et al., 2013), and in healthy middle-aged male 523 
subjects (Wang, Zhao, Wang, Huo & Ji, 2016). 524 
5.2 Anthocyanins in blueberries 525 
Mice that were fed a HFD and also had their drinking water supplemented with purified ACNs 526 
from blueberries, instead of whole blueberry, showed decreased serum TG and TC levels that 527 
were comparable with those of the lean control group (10% of kcal from fat) (Prior et al., 2009). 528 
This result indicated that sugars or other components in the whole fruits were possibly masking 529 
the benefits of ACNs and other components of blueberries. It should be noted that blueberry 530 
polyphenol was effective on serum TC level in C57BL/6 mice, which was 13.2% lower than 531 
in the control group  (Roopchand, Kuhn, Rojo, Lila & Raskin, 2013). A human trial  which 532 
investigated the effect of  ACNs (from bilberry) supplementation on lipid profiles in 533 
dyslipidemic patients found that 160 mg of ACNs supplementation for 12 weeks increased 534 
cellular cholesterol efflux and HDL-C concentrations, as well as reduced the mass and activity 535 
of plasma cholesteryl ester transfer protein (CETP) and LDL-C concentrations, without 536 
affecting TC levels (Qin et al., 2009). Zhu et al. (2013) also found similar results, reporting 537 
that volunteers with hypercholesterolemia had greater reductions in LDL-C levels and greater 538 
increases in HDL-C after consuming 320 mg/day of purified ACNs for 24 weeks compared 539 
with controls. In an in vitro study, C3G reduced CETP activity in human HepG2 cells in a 540 
dose-dependent manner, suggesting that supplementation of ACNs may improve lipoproteins 541 
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by increasing HDL-C concentrations and decreasing serum LDL-C partially due to the 542 
inhibition of  CETP target (Zhu et al., 2013). Other possible mechanisms by which blueberry 543 
ameliorates lipid profile are possibly related to the intact assimilation of blueberry bioactivity 544 
such as ACNs, which exhibited the antioxidant properties in serum and other tissues (Mazza, 545 
Kay, Cottrell & Holub, 2002; Mcghie, Ainge, Barnett, Cooney & Jensen, 2003). Studies have 546 
revealed that the high concentration of ACNs in wild blueberry is a major contributor to the 547 
antioxidant properties in vitro, instead of other antioxidant minerals, vitamins, or fibres (Prior 548 
et al., 1998). Moreover, the antioxidant properties of ACNs have been confirmed via other 549 
systems of oxidation such as that for the prevention of LDL oxidation in vitro (Laplaud, 550 
Lelubre & Chapman, 1997). It has been validated that ACNs can be absorbed intact in 551 
glycosylated and possibly acylated forms in male volunteers after the consumption of 552 
blueberries (Wu, Cao & Prior, 2002). Moreover, the presence of ACNs in the serum may be 553 
involved with a diet-induced increase in ex vivo serum antioxidant status (Mazza, Kay, Cottrell 554 
& Holub, 2002). 555 
Taking all these data together, it can be concluded that blueberries and blueberry extracts may 556 
potentially improve dyslipidaemia by regulating TG, cholesterol and fatty acid metabolism  557 
through several signalling pathways. However, further studies are necessary to better clarify 558 
the mechanisms involved in these actions of bioactive components in blueberries. 559 
6. Effect on inflammation and adipocytokine profile  560 
Obesity is associated with systemic chronic inflammation, and this low-grade inflammation 561 
may play an important  role in obesity associated insulin resistance, T2D, and other 562 
complications (Calder et al., 2011; Chen, Chen, Wang & Liang, 2015; Gabay, 2006; Giugliano, 563 
Ceriello & Esposito, 2006). A diet enriched in vegetables and fruits is inversely related to 564 
inflammatory stress, compared with meals that are energy dense which induce an acute 565 
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inflammatory status in both overweight and healthy adults (Calder et al., 2011; Manning et al., 566 
2008; Root et al., 2012; Vendrame, Daugherty, Kristo, Riso & Klimis-Zacas, 2013). 567 
Blueberries contain various anthocyanins, phenolic acid and other bioactive components 568 
recognized for their ability to provide and activate cellular antioxidant protection, scavenge 569 
free radicals, inhibit inflammatory gene expression, and consequently protect against oxidant-570 
induced and inflammatory cell damage and cytotoxicity (Johnson, De Mejia, Fan, Lila & 571 
Yousef, 2013; Kang, Thakali, Jensen & Wu, 2015; Nile & Park, 2014).  572 
Dietary supplementation with 8% blueberries to Obese Zucker rats for 8 weeks has been 573 
reported to decrease plasma concentrations of IL-6, TNF-α and CRP compared with the control 574 
group (Vendrame, Daugherty, Kristo, Riso & Klimis-Zacas, 2013). Furthermore, in this study, 575 
expression of TNF-α, IL-6 and NF-κB was down-regulated in both the AAT and the liver, 576 
whereas CRP expression was down-regulated only in the liver (Vendrame, Daugherty, Kristo, 577 
Riso & Klimis-Zacas, 2013). Similarly, supplementation with 4% whole blueberry powder 578 
deceased IL-10 and TNF-α mRNA expression in  adipose tissue inflammation of HFD fed 579 
C57BL/6J mice, but no significant changes in other inflammatory biomarkers, such as nitric 580 
oxide synthase (iNOS), IL-6 and MCP-1 (Defuria et al., 2009).  581 
Bilberry consumption has also been demonstrated to attenuate pro-inflammatory responses 582 
induced by HFD in C57BL/6J mice fed with a 5% or 10% (w/w) of whole bilberries for three 583 
months, via reduction in MCP-1, IL-2, IL-1β, IL-6 and TNF-α (Mykkanen et al., 2014). In 584 
particular, the levels of IL-15 and interferon gamma (IFN-γ) were increased in non-585 
supplemented HFD fed animals and reduced to non-detectable levels in animals that were 586 
supplemented with bilberries (Mykkanen et al., 2014). In contrast, to the bilberry studies, 587 
dietary supplementation with a blueberry pomace by-product failed to alter mRNA expression 588 
of CD68 (an anti-inflammatory marker) and CRP in adipose tissue of Syrian Golden hamsters 589 
compared to controls (Kim, Bartley, Rimando & Yokoyama, 2010). One explanation for the 590 
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inconsistency in these findings may be associated with different components among 591 
blueberries, its fractions and its peel. 592 
During the last few years a number of clinical trials have been carried out to assess the potential 593 
anti-inflammatory function of blueberry supplementation in subjects who are obese and have 594 
other disorders of metabolic syndrome (Table 2). Karlsen et al. (2010) reported that intake of 595 
bilberry juice could regulate inflammatory mediators such as, IL-6, IL-15 and CRP in men and 596 
women as well as improve the levels of plasma polyphenols.  Furthermore, it was found that 597 
the decrease of these inflammatory mediators were associated with NF-κB activation (Karlsen 598 
et al., 2010). In a preclinical study, dietary supplementation with 400 g of bilberry for 8 weeks 599 
decreased serum IL-6, IL-12, high sensitivity-CRP (hsCRP) and LPS concentrations in obese 600 
individuals with low-grade inflammation (Kolehmainen et al., 2012). However, in another 601 
study where 110 female volunteers consumed 100 g of fresh blueberry fruits for 33–35 days, 602 
there were no differences observed in TNF-α between the baseline and treatment group at the 603 
end of the intervention (Lehtonen et al., 2011). Similarly no alterations in plasma IL-6 and CRP 604 
concentrations were observed in obese participants following consumption of freeze-dried 605 
blueberries (50 g) for 8 weeks (Basu et al., 2010). Another study demonstrated that 606 
consumption of blueberries (22.5 g) for 6 weeks did not   affect  the inflammatory biomarker 607 
profile including TNF-α, hsCRP and MCP-1 in obese, nondiabetic, and insulin-resistant 608 
volunteers (Stull, Cash, Johnson, Champagne & Cefalu, 2010). Perhaps the contradictions in 609 
the observed impacts on inflammatory markers in these clinical studies may at least in part be 610 
explained by the use of different species of berries [bilberry (Karlsen et al., 2010; Kolehmainen 611 
et al., 2012) vs. blueberry (Basu et al., 2010; Lehtonen et al., 2011; Stull, Cash, Johnson, 612 
Champagne & Cefalu, 2010)], the amount of berries consumed; type of serum samples used 613 
for measuring inflammatory biomarkers [fasting serum (Karlsen et al., 2010; Kolehmainen et 614 
al., 2012) vs. non-fasting serum (Stull, Cash, Johnson, Champagne & Cefalu, 2010)] or the 615 
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status of these individuals [overweight subjects with 25.6 ± 6.1 of BMI) (Karlsen et al., 2010) 616 
vs. obese subjects with 36.8 ± 0.9 of BMI (Stull, Cash, Johnson, Champagne & Cefalu, 2010) 617 
and 38.1 ± 1.5 of BMI (Basu et al., 2010)].  618 
It has been reported that a purified ACN mixture exhibited higher anti-inflammatory activity 619 
compared to single ACN or whole berries in vitro and in vivo (Zhu et al., 2013). In that study, 620 
purified anthocyanin mixture (containing 17 ACN compounds from blueberries) produced a 621 
stronger inhibitory effect on IL-6, IL-1β-induced CRP production in HepG2 cells and LPS-622 
induced vascular cell adhesion molecule-1 (VCAM-1) secretion in endothelial cells, 623 
respectively, compared with the effects of single anthocyanin, D3G and C3G, which support 624 
the observations in human subjects (Zhu et al., 2013). These studies suggest that the various 625 
ACNs in blueberry may act synergistically to inhibit the inflammatory response. Hence, 626 
consuming foods rich in different ACNs is likely to be more beneficial than consuming a single 627 
ACN supplement. 628 
Blueberry and its extracts have also demonstrated potential benefits on the regulation of 629 
adipocytokines in animal and human studies. The concentration of adiponectin was higher in 630 
C57BL/6J obese mice fed HFD and genetically diabetic db/db mice with C3G supplementation, 631 
compared with mice only fed a HFD diet (Guo et al., 2012; Liu, Li, Zhang, Sun & Xia, 2014). 632 
Similarly, wild blueberry consumption in Obese Zucker rats resulted in a significant increase 633 
in circulating adiponectin level compared to the control group (+ 21.8%) (Vendrame, 634 
Daugherty, Kristo, Riso & Klimis-Zacas, 2013). Adiponectin concentration, however has been 635 
demonstrated not to differ from the control groups following supplementation of blueberry or 636 
ACNs in several animal studies (Mykkanen et al., 2014; Roopchand, Kuhn, Rojo, Lila & 637 
Raskin, 2013; Takikawa, Inoue, Horio & Tsuda, 2010; Vuong et al., 2009; Wu et al., 2013) 638 
and human trials (Basu et al., 2010; Kolehmainen et al., 2012; Qin et al., 2009). Lehtonen et 639 
al. (2011) demonstrated, however a decrease in adiponectin level after bilberry 640 
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supplementation in overweight and obese women for 33-35 days. Therefore the exact effect of 641 
consumption of blueberries on adiponectin level is unclear. 642 
Leptin secretion has been demonstrated to be inhibited by diets enriched with blueberry, both 643 
in genetic models of obesity and dietary-induced obese animal models (Prior et al., 2010; Prior 644 
et al., 2009; Wu et al., 2013). However, no significant effect was observed on leptin levels in 645 
other animal studies (Mykkanen et al., 2014; Vuong et al., 2009), or indeed in a human trial 646 
(Kolehmainen et al., 2012).  647 
Resistin is a hormone secreted from adipose tissue and it has been implicated in the modulation 648 
of insulin action, energy, glucose and lipid homeostasis and also has been linked to the onset 649 
of insulin resistance and obesity-associated diabetes (Abate et al., 2014).  Mykkane et al. (2014) 650 
investigated the effect of blueberry supplementation (10% wild blueberry) in mice fed a HFD 651 
and indicated that serum resistin level was significantly reduced in the mice that were 652 
supplemented with blueberry for 12-14 weeks.   653 
There are several potential mechanisms involved in the anti-inflammatory properties of 654 
blueberry. Firstly, antioxidants in blueberry, such as polyphenols and ACNs which exhibit the 655 
anti-inflammatory effect may be dependent on a reduction of pro-inflammatory cytokines and 656 
increase of anti-inflammatory mediators such as adiponectin (Guo et al., 2012). Secondly, 657 
oxidative stress, which  leads to inflammation is reduced due to the strong antioxidant activity 658 
of blueberries and its extracts, which is subsequently involved in an increase of glutathione 659 
peroxidase 3 (a sensitive index of oxidative stress) gene expression (Lee et al., 2008). Thirdly, 660 
blueberry or its ACNs may be able to alter mitogen-activated protein kinase signalling, which 661 
modulate cell fate and inflammatory gene expression in various tissues and macrophages 662 
(Suganami et al., 2007). Finally the attenuation of NF-κB activation could be related to the 663 
antioxidant capacity of blueberries or its extracts, thereby providing a potential mechanism 664 
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with the observed anti-inflammatory effect of blueberry intake (Vendrame, Daugherty, Kristo, 665 
Riso & Klimis-Zacas, 2013). 666 
7. Conclusion  667 
This review focused on blueberries and their bioactive components that influence obesity and 668 
its related comorbidities, although it is necessary to indicate that there are still a large number 669 
of phytonutrients in blueberries under exploration at present, especially ACNs. A major 670 
question to be addressed is whether a single purified component or constituent in blueberries 671 
such as C3G or ACNs, or multiple constituents in this fruit produced synergic effects on human 672 
health. In addition, there is a need for determining the bioactive constituents of blueberry and 673 
their metabolites, which may accumulate in the target tissues and exert biological effects.  674 
Future studies could also focus on the interactions of nutrients and genes so we have a better 675 
understanding of the beneficial effects of blueberry at the molecular level, thus be able to 676 
develop effective intervention strategies and achieve better outcomes.  According to the 677 
literature, the evidence suggests that several species of blueberries in the genus Vaccinium and 678 
their isolated compounds  are potential contributors to the regulation of glucose, lipid 679 
metabolism and improvement of inflammation.  A deep understanding of the potential roles of 680 
blueberries in controlling body weight, regulating blood glucose, and attenuating dyslipidaemia 681 
and related chronic inflammation will guide further rigorous investigations on the underlying 682 
mechanisms of their beneficial effects on health. 683 
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